No annual revenue total was found in Greenland Mines Ltd.'s SEC filings.
Greenland Mines Ltd. (GRML) files with the SEC under industry code 2836, Biological Products, (No Diagnostic Substances).
Revenue
—
Net income (TTM)
$-21.77M
-91.7% vs year-ago TTM
Operating cash flow (TTM)
$-14.22M
-158.2% vs year-ago TTM
Free cash flow
—
EPS (TTM)
$-0.25
+41.6% vs year-ago TTM
Dividend per share
$16.50
+0.0% vs prior year
Shares outstanding
121.24M
+325.2% vs prior year
Net cash
—
Operating margin
—
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- GRML (Nasdaq), GRMLW (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Omaha, NE
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1907223
- Former names
- Klotho Neurosciences, Inc. (until Mar 10, 2026); ANEW Medical, Inc. (until Sep 18, 2024); Redwoods Acquisition Corp. (until Jun 21, 2024)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| Operating income | -$7.1M | -$5.5M | -$631,322 | -$657,018 |
| Net income | -$10.6M | -$6.2M | -$707,458 | $1.2M |
| Diluted EPS | -$0.22 | -$0.32 | — | — |
| Operating cash flow | -$5.9M | -$2.9M | -$446,916 | -$493,043 |
| Total assets | $9.6M | $2.5M | $2.2M | $118.2M |
| Total liabilities | $129,764 | $1.3M | $1.6M | $4.9M |
| Stockholders' equity | $9.5M | $1.2M | -$442,701 | -$4.0M |
| Cash and investments | $7.2M | $63,741 | $2,808 | $340,962 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Oct 2, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 28, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 23, 2026 | Sep 21, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 11, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Bylaw or fiscal year change, Shareholder vote results
|
Sep 4, 2026 | Sep 1, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 27, 2026 | Aug 26, 2026 |
All 268 Greenland Mines Ltd. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.